JP5624766B2 - アルコールを含まないアルガトロバン製剤 - Google Patents

アルコールを含まないアルガトロバン製剤 Download PDF

Info

Publication number
JP5624766B2
JP5624766B2 JP2009530403A JP2009530403A JP5624766B2 JP 5624766 B2 JP5624766 B2 JP 5624766B2 JP 2009530403 A JP2009530403 A JP 2009530403A JP 2009530403 A JP2009530403 A JP 2009530403A JP 5624766 B2 JP5624766 B2 JP 5624766B2
Authority
JP
Japan
Prior art keywords
salt
argatroban
formulation
pharmaceutically acceptable
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009530403A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010504971A5 (enExample
JP2010504971A (ja
Inventor
ナゲスワラ・アール・パレプ
Original Assignee
イーグル・ファーマシューティカルズ・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39230808&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5624766(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by イーグル・ファーマシューティカルズ・インコーポレーテッド filed Critical イーグル・ファーマシューティカルズ・インコーポレーテッド
Publication of JP2010504971A publication Critical patent/JP2010504971A/ja
Publication of JP2010504971A5 publication Critical patent/JP2010504971A5/ja
Application granted granted Critical
Publication of JP5624766B2 publication Critical patent/JP5624766B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2009530403A 2006-09-27 2007-09-26 アルコールを含まないアルガトロバン製剤 Active JP5624766B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US84755606P 2006-09-27 2006-09-27
US60/847,556 2006-09-27
US85072506P 2006-10-11 2006-10-11
US60/850,725 2006-10-11
PCT/US2007/020725 WO2008039473A2 (en) 2006-09-27 2007-09-26 Alcohol free formulation of argatroban

Publications (3)

Publication Number Publication Date
JP2010504971A JP2010504971A (ja) 2010-02-18
JP2010504971A5 JP2010504971A5 (enExample) 2013-04-18
JP5624766B2 true JP5624766B2 (ja) 2014-11-12

Family

ID=39230808

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009530403A Active JP5624766B2 (ja) 2006-09-27 2007-09-26 アルコールを含まないアルガトロバン製剤

Country Status (5)

Country Link
US (1) US7589106B2 (enExample)
EP (1) EP2083823A4 (enExample)
JP (1) JP5624766B2 (enExample)
CA (1) CA2669727C (enExample)
WO (1) WO2008039473A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7915290B2 (en) * 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
HUE045889T2 (hu) 2010-10-21 2020-01-28 Rtu Pharmaceuticals Llc Használatkész ketorolak készítmények
EP2884963B1 (en) * 2012-08-15 2017-12-27 Yung Shin Pharm. Ind. Co. Ltd. Stable pharmaceutical formulation of cabazitaxel
US9636376B2 (en) 2012-09-11 2017-05-02 Innopharma, Inc. Stable compositions of peptide epoxy ketones

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214052A (en) 1987-07-28 1993-05-25 Mitsubishi Kasei Corporation Method for dissolving arginineamides and pharmaceutical compositions containing them
US5506241A (en) 1992-03-18 1996-04-09 Mitsubishi Chemical Corporation Argatroban preparations for ophthalmic use
JPH06219948A (ja) 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
JPH06219949A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
JPH07228532A (ja) * 1993-04-22 1995-08-29 Senju Pharmaceut Co Ltd 水性液剤、その有効成分の溶解性向上方法および安定化方法
TW256831B (enExample) 1993-04-22 1995-09-11 Senju Pharma Co
FR2715566B1 (fr) 1994-02-03 1996-03-08 Synthelabo Solutions aqueuses concentrées d'argatroban.
CA2345641A1 (en) 1998-09-28 2000-04-06 Merck & Co., Inc. A method for treating inflammatory diseases by administering a thrombin inhibitor
US6495534B2 (en) 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
EP1389209B1 (en) 2001-04-24 2009-04-08 Purdue Research Foundation Folate mimetics and folate-receptor binding conjugates thereof
WO2004026252A2 (en) 2002-09-23 2004-04-01 The Regents Of The University Of Michigan Glioma treatments
CN101257890B (zh) * 2005-09-01 2012-10-31 巴克斯特国际公司 含有酸作为增溶剂的阿加曲班制剂

Also Published As

Publication number Publication date
US20080076798A1 (en) 2008-03-27
WO2008039473A2 (en) 2008-04-03
US7589106B2 (en) 2009-09-15
CA2669727A1 (en) 2008-04-03
EP2083823A4 (en) 2010-01-13
WO2008039473A3 (en) 2008-06-12
EP2083823A2 (en) 2009-08-05
CA2669727C (en) 2014-10-28
JP2010504971A (ja) 2010-02-18

Similar Documents

Publication Publication Date Title
JP2017514924A (ja) シクロホスファミド液状濃縮物の製剤
CN107810000B (zh) 来氟米林的可注射药物组合物
US7094414B2 (en) Famotidine injections
TW201836609A (zh) 包含硼替佐米（bortezomib）之穩定調配物及其製備方法
JP2010504971A (ja) アルコールを含まないアルガトロバン製剤
JP6347784B2 (ja) 神経筋遮断薬の安定化水性組成物
JP7837563B2 (ja) そのまま安定に希釈するためのカルフィルゾミブ製剤
JP2010504971A5 (enExample)
JP3781308B2 (ja) アルギニンアミド類を含有する医薬製剤
JPH0576929B2 (enExample)
JP2001163776A (ja) 安定化された液剤
WO2008045410A2 (en) Alcohol free formulation of argatroban
US20130023559A1 (en) Alcohol free formulation of argatroban
JPH11228404A (ja) 安定な水性点眼剤
CN101516370A (zh) 阿加曲班的无醇制剂
AU2008250717A1 (en) Aqueous pharmaceutical preparation
HK1131895A (en) Alcohol free formulation of argatroban
WO2019130228A1 (en) Stable liquid compositions of melphalan
JP2009256281A (ja) イソプロピルウノプロストン含有点眼剤組成物
US7687516B2 (en) Alcohol free formulation of argatroban
WO2004096229A1 (ja) 溶液医薬組成物
TW201106961A (en) Ipamorelin diacetate injection and infusion solutions
JP2628020B2 (ja) 医薬製剤用水溶液
TR2021002013A2 (tr) Injectable composition comprising emoxypine
JP6854710B2 (ja) ペメトレキセドを含有する注射用溶液製剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100903

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121204

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20130304

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131203

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140218

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140225

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140602

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140722

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140813

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140902

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140929

R150 Certificate of patent or registration of utility model

Ref document number: 5624766

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250